Shots
• HLTH Europe 2026 brought together over 5,000 healthcare leaders, investors, policymakers, payers, providers, pharmaceutical executives, and digital health innovators in Amsterdam to explore the future of healthcare innovation.
• Healthcare has a paradox: brilliant point solutions are failing not because they don’t work, but because they can’t talk to each other. A patient monitored more comprehensively than any in history has fragmented data scattered across incompatible systems, crippling decision-making and outcomes.
• The companies reshaping healthcare aren’t building the next clinical innovation, they’re building the connective tissue between solutions. Orchestration platforms, data aggregation layers, and interoperability infrastructure have become more valuable than any individual point solution.
When Innovation Meets Reality – The Integration Crisis Reshaping Healthcare
Amsterdam in June carries a particular electricity. The canal-side venues of HLTH Europe 2026 were alive with the energy of over 5,000 healthcare leaders, investors, founders, physicians, and policymakers who gathered to chart the future of healthcare innovation. But this year felt different. Beneath the optimism ran a current of pragmatism—even frustration—that would prove to be the conference’s most important revelation.
I spent a full week moving between keynote halls and conversation clusters. Founders pitching breakthrough solutions. CXOs from Europe’s largest health systems explaining why brilliant technologies fail to deploy. Clinicians asking pointed questions about workflow integration that never made it into the presentations. By the third day, a pattern became impossible to ignore.
The central truth nobody was explicitly stating: the gap between what technology can do and what healthcare actually needs has become the hidden crisis of modern healthcare innovation.
The Elephant in Every Room
Let me describe a moment that crystallized this insight. I was sitting across from the Chief Experience Officer of a major European health system—someone overseeing digital transformation for roughly 50,000 employees across multiple hospitals. She had just watched an impressive AI pitch. Real clinical validation. Measurable metrics. Clear ROI projections on paper.
“It’s excellent,” she said quietly. “I probably won’t implement it.”
“Why?” I asked.
“Because it doesn’t talk to the system we already use. My cardiologists work in one platform, my pulmonologists in another, my emergency department in a third. You’re presenting a brilliant point solution to a systems problem. Every new tool you add makes integration harder, not easier.”
This conversation played out seven times during the week. Different decision-makers. Different technologies. Different clinical domains. Same conclusion.
Everyone in healthcare says they want AI innovation. What they actually need is for innovation to disappear seamlessly into their existing workflows without disruption. They need solutions that integrate with what already exists, not demand that everything be replaced.
This is the silent killer of otherwise brilliant healthcare companies. Not a lack of innovation. Not insufficient clinical evidence. Integration.
A Week of Revelation
HLTH Europe 2026 unfolded across four days of focused discussions that revealed where healthcare innovation actually stands—and where the real opportunity lies.
Day One: From Experimentation to Execution
The opening day set a clear agenda: healthcare has moved beyond pilot projects. The Health Transformation Summit brought together executives, policymakers, and innovation leaders to address the mounting pressures on healthcare systems—rising costs, workforce shortages, growing patient demand. But the tone was different than previous years.
The conversation centered on one shift: artificial intelligence is moving from proof-of-concept to enterprise implementation. Industry experts discussed practical pathways for integrating AI into clinical and operational workflows, with emphasis on governance, trust, transparency, and measurable return on investment. Healthcare organizations are no longer asking “Can AI work?” They’re asking “How do we deploy AI effectively without disrupting what’s already working?”
Workforce transformation emerged as equally urgent. Multiple sessions examined how automation, ambient documentation technologies, and digital tools can reduce administrative burden and improve clinician experience. But speakers repeatedly emphasized a critical point: technology should enhance healthcare professionals, not replace them. The goal is reducing clinician burden and burnout, not simply chasing efficiency metrics.
Policy and regulatory considerations remained central. European healthcare leaders underscored the need for stronger interoperability standards, responsible AI governance frameworks, and cross-border collaboration to enable innovation at meaningful scale.
The day’s takeaway was unmistakable: healthcare leaders are increasingly focused on transforming innovation into measurable clinical, operational, and economic outcomes that drive sustainable transformation.
Day Two: When AI Stops Being a Concept
The second day placed artificial intelligence deployment and healthcare data transformation at the forefront. The mindset shift was palpable: organizations are moving beyond exploring AI’s theoretical potential and focusing on deploying solutions that deliver measurable value across clinical, operational, and financial domains.
AI agents and their expanding role in healthcare became a primary topic. Industry leaders discussed how advanced AI systems are increasingly integrated into clinical decision support, patient engagement, administrative processes, and revenue cycle management. But the conversation reflected a maturation: healthcare organizations are prioritizing governance, scalability, and real-world performance over proof-of-concept experiments.
Data interoperability and real-world evidence emerged as foundational requirements. Experts highlighted how connected healthcare ecosystems—built on unified patient records, secure data-sharing frameworks, and better utilization of healthcare data—are becoming essential. Interoperability isn’t optional anymore. It’s the prerequisite for enabling innovation and generating actionable insights that actually improve outcomes.
The digital health landscape attracted intense focus from investors and healthcare executives. A clear expectation has emerged: digital health companies must demonstrate sustainable clinical and economic impact, not just engagement metrics. As funding environments become more selective, evidence-based technologies capable of integrating into existing workflows are increasingly favored.
Leading organizations shaped these conversations—Mayo Clinic, Vanderbilt University Medical Center, Charité – Universitätsmedizin Berlin, Sahlgrenska University Hospital. Their collective perspective was clear: healthcare institutions are leveraging technology, data, and collaboration to accelerate transformation, but only when solutions fit into existing care delivery models.
The day concluded with one unmistakable message: healthcare has stopped asking what AI can theoretically achieve. The focus is now on how AI can be implemented safely, responsibly, and effectively at scale to drive meaningful improvements.
Day Three: The Innovation Ecosystem Under the Microscope
The third day spotlighted the startup ecosystem and emerging technologies transforming healthcare. The Startup Innovation Showcase attracted intense interest, with emerging companies presenting solutions across AI-powered diagnostics, clinical workflow automation, women’s health, mental health, care navigation, and digital therapeutics. The common thread: practical applications solving real operational challenges and improving patient experiences.
One thing became immediately apparent walking the showcase floor: healthcare innovation is extraordinarily diverse. Companies are solving brutally specific problems with elegant solutions. But they’re solving them in isolation.
Hospital executives shared lessons from implementing advanced technologies. Predictive analytics, virtual care platforms, capacity optimization strategies—when integrated thoughtfully into existing workflows, these technologies improved resource allocation and enabled more proactive care. The consistent insight: success happens when technology aligns with organizational goals and integrates seamlessly into clinical operations.
Investment trends reflected a maturing market. More than 300 investors attended, focusing on areas including artificial intelligence infrastructure, clinical productivity tools, real-world evidence platforms, and preventive healthcare solutions. But the investment thesis has shifted: solutions demonstrating sustainable business models, strong clinical evidence, and scalability across healthcare systems are increasingly favored over point solutions with limited integration pathways.
Value-based care was another prominent theme, with experts exploring outcome-driven reimbursement models and risk-sharing partnerships that align incentives around patient outcomes rather than volume. This shift creates both opportunity and pressure: technology that improves efficiency and demonstrates measurable outcomes is rewarded. Everything else struggles.
Day Four: Building Healthcare That Actually Works
The final day focused on the industry’s most critical priority: translating innovation into sustainable transformation. Discussions centered on implementation strategies, prevention, ecosystem collaboration, and long-term healthcare sustainability.
Prevention emerged as a dominant theme. Healthcare leaders advocated for shifting from reactive treatment to proactive health management. Early intervention, population health strategies, chronic disease prevention, and personalized care pathways are reshaping how organizations think about long-term health outcomes. The economics are compelling: prevention not only improves patient health but reduces costs and alleviates pressure on overstretched systems.
One of the most significant discussions focused on GLP-1 therapies and their implications extending far beyond obesity management. Industry experts explored broader implications for metabolic health, cardiovascular outcomes, employer health strategies, and long-term disease prevention. The consensus: GLP-1 therapies represent a fundamental shift in how healthcare approaches chronic disease prevention, with potential to reshape care models and healthcare economics.
Collaboration remained the through-line across all four days. Healthcare leaders unanimously emphasized that meaningful transformation cannot happen through isolated organizational efforts. Success requires stronger partnerships among providers, payers, pharmaceutical companies, technology innovators, and policymakers. Data sharing, incentive alignment, and integrated care ecosystems are no longer ideals—they’re prerequisites.
The Companies That Are Getting It Right
Walking the conference floor, I encountered remarkable innovation addressing specific healthcare challenges. Each deserves attention because each solves a real problem elegantly.
Shen AI transforms digital health accessibility with advanced AI-powered health monitoring. A 30-second smartphone face scan captures vital signs including blood pressure, heart rate, HRV, and respiratory rate. Their SDK enables seamless integration into existing applications and platforms, delivering accurate measurements without physical devices. For healthcare providers and insurers, this means scalable, efficient health monitoring at the point where patients are—using technology they already carry.
Lapsi Health’s Keikku, an AI-powered clinical platform designed to support clinicians throughout the patient consultation journey, combines an FDA-cleared digital stethoscope with intelligent clinical documentation capabilities. A doctor listens to a patient’s heart and lungs. The AI captures those sounds, analyzes them, and automatically transcribes findings into structured clinical data. Point-of-care documentation barrier eliminated. Data captured in forms that can actually be used downstream.
PicoCare addresses one of healthcare’s most persistent problems: medication adherence among elderly patients. Patients miss doses, take wrong doses, forget entirely. The consequences are preventable hospital readmissions and declined health. PicoCare built an elegant medication dispensing and adherence device that measures compliance improvement and demonstrates genuine readmission reduction.
Psylaris delivers evidence-based mental health therapy via VR directly into patients’ homes. No waiting lists. No geographic barriers. Lower cost than traditional delivery. They’ve managed to solve two healthcare problems simultaneously—access and economics—by fundamentally changing the delivery model.
HaloScape reimagines health monitoring through smart mirrors, making continuous vital sign monitoring so seamless that patients actually engage with it rather than ignoring another device.
United Imaging Healthcare harnesses AI to extract unprecedented levels of detail and specificity from medical imaging. Their AI-powered platform doesn’t replace radiologists—it augments them, surfacing patterns and details that might otherwise be missed, enabling more accurate diagnoses in less time.
Remind doesn’t treat disease—it catches it before it starts. By identifying early warning signals like exhaustion, stress, and burnout patterns that precede neurological diseases like dementia and Parkinson’s, they’ve positioned early intervention as prevention.
Skin Analytics solves the barrier problem. A smartphone scan provides cancer risk assessment in seconds at the moment patients are actually looking—in a mirror at home. Early detection happens where access actually exists.
CC Diagnostics is tackling cervical cancer detection with technology that could transform screening in regions where diagnostic access is limited.
AIKON Health focuses on cardiac patients specifically, reducing readmissions by monitoring vital signs and medication adherence in patients at highest risk.
Each company is phenomenal at what it does. Each solves a real clinical problem. Each demonstrates genuine value and measurable ROI.
And almost none of them talk to each other.
The Architecture of Fragmentation
Here’s where the real story emerges.
Imagine a 68-year-old woman with heart failure. She visits her cardiologist, who uses Lapsi’s Keikku to examine her heart sounds. AI captures the audio, transcribes findings, and records them in the hospital’s electronic health record. Problem solved: clear documentation, structured data, measurable improvement.
She goes home with a new medication regimen. She uses PicoCare’s medication dispenser to ensure she doesn’t miss doses. Adherence improves. Outcomes improve.
She’s also pre-diabetic, so her physician prescribes Withings devices—a smart scale, blood pressure monitor, activity tracker. Real-time data flows to her phone and care provider. Continuous visibility into her health status.
Now consider what actually happens in the system:
Keikku data lives in the hospital’s electronic health record. Medication adherence data lives in PicoCare’s system. Continuous monitoring data lives in Withings’ ecosystem. Her cardiologist sees one picture. Her primary care physician sees another. Her endocrinologist sees a third. Her mental health provider, if she has one, sees yet another.
If she visits the emergency department with chest pain, the triage nurse accesses EHR data but not recent adherence information or continuous monitoring data. The emergency physician makes critical decisions with incomplete information—not because the information doesn’t exist, but because it doesn’t flow between systems.
Add a pulmonologist. Add an immunologist. Add a specialist in another country. What emerges is a patient monitored more comprehensively than any patient in history, yet whose data is fundamentally fragmented across incompatible systems.
Each individual data source is excellent. Each tool solves a real problem elegantly. The system is broken.
This is not a problem that additional point-solution innovation can fix. No amount of breakthrough invention at the edges addresses the fundamental architecture problem at the center.
The Companies Building the Connective Tissue
The conversations that reframed my entire understanding came from a different group of companies. Not the ones building the next clinical innovation. The ones building the layer between solutions.
Withings, Heidi, and Tandem Health (in their platform approaches) aren’t primarily competing on clinical innovation. They’re competing on integration. They’re the connective tissue trying to stitch together disparate data sources across healthcare facilities.
They’re not saying: “We have better vital sign monitoring.” They’re saying: “We can take vital data from any source and make it available everywhere it’s needed, in the format it’s needed.”
They’re not saying: “We have superior diagnostics.” They’re saying: “We can aggregate diagnostic data from multiple systems and surface the most relevant insights to the right decision-maker at the right time.”
They understand something fundamental that most healthcare innovators miss: in a fragmented system, the infrastructure layer becomes more valuable than any individual innovation built on top of it.
One conversation stands out. An executive from a company building orchestration platforms—the software translating between incompatible healthcare IT systems—said something that captured the moment perfectly:
“Everyone gets excited about AI. Everyone wants automation and better decisions and faster care. But in a fragmented system, you can’t get there. You can’t automate what you can’t see. You can’t make better decisions with incomplete data. You can’t accelerate care when clinical information is scattered across five different systems.”
The uncomfortable implication: most healthcare innovation is happening in the wrong layer.
What Actually Drives Adoption
Across hundreds of conversations during the week, three patterns emerged consistently from real decision-makers:
Measurable Proof Trumps Theoretical Capability
CXOs don’t care what AI could do in an ideal scenario. They care what it actually does in their hospital, on their patient population, in their workflow. Show them 15% readmission reduction. Show them 30-minute ED wait time improvement. Show them cost per patient per year declining. Those metrics change behavior. Theoretical capability does not.
Speed to Value Beats Perfection
Health systems moving fastest aren’t the ones with the biggest budgets or best infrastructure. They’re the ones willing to start small, deploy imperfectly, learn from real-world implementation, and iterate based on actual clinical feedback. They’re shipping incomplete solutions into production and improving them live. The cautious players waiting for perfect technology and perfect implementation plans are still in planning committees while the market has moved on.
Infrastructure Determines Whether Everything Works
This insight reframes the entire industry landscape. Brilliant point solutions fail when they can’t connect to the broader ecosystem. Integration capacity, not innovation capacity, becomes the limiting factor.
The Question Hiding in Plain Sight
By week’s end, I’d fundamentally reframed how I think about healthcare innovation.
We don’t lack brilliant solutions to clinical problems. We have an embarrassment of riches. Picocare solves medication adherence. Lapsi solves documentation. pScilaris solves access. Skin Analytics solves early detection. Remind solves early intervention. Each is excellent. Each is real.
The question isn’t: “Can we build better AI?” We clearly can.
The question is: “How do we stitch all of this excellence together into something that functions as a coherent system?”
That’s the real bottleneck. Not innovation capacity. Not clinical validation. Integration.
Here’s the uncomfortable truth for most healthcare startups: you can build the most brilliant clinical AI in the world, validate it impeccably, demonstrate clear ROI—and still fail to get adopted because you exist in a fragmented ecosystem that doesn’t know how to connect you to everything else.
The companies I’m watching most closely aren’t pitching the next AI breakthrough. They’re unglamorously building infrastructure that lets different systems talk to each other. Orchestration platforms. Data aggregation layers. Interoperability solutions.
Not exciting. Not the kind of thing generating standing ovations at conferences. But absolutely critical to whether the rest of the innovation actually matters.
What This Means Going Forward
HLTH Europe 2026 demonstrated that healthcare has entered a new era—one defined not by innovation in isolation, but by the ability to operationalize it at scale and deliver measurable value.
For founders building in healthcare, the question is stark: Are you building a brilliant isolated solution to a specific problem? Or are you building toward enabling a system?
Both matter. Both can be valuable. But they require entirely different strategies.
If you’re building a brilliant isolated solution, validate the clinical outcome, demonstrate ROI, find the specific customer segment that needs exactly what you’ve built, and own that segment deeply. This path is clear.
But if you’re honest about existing in a fragmented ecosystem—that your solution works best when connected to others—you need a different strategy entirely. Think about integration from day one. Choose integration partners carefully. Design your product not just to solve a problem, but to feed into a broader system.
The future of healthcare won’t be built by one company solving everything. It will be built by many companies solving specific things well, connected by infrastructure that makes them work together as a system.
The Collaborative Future
One of HLTH Europe 2026’s most compelling observations: healthcare practitioners are becoming entrepreneurs and innovators. Clinicians, physicians, nurses, and healthcare leaders are identifying gaps in healthcare systems and developing solutions. They’re leveraging frontline experience to solve real-world challenges.
The conference reinforced that transformation cannot happen in silos. As healthcare systems worldwide navigate rising costs, workforce pressures, fragmented data ecosystems, and growing patient expectations, collaboration has become essential.
Healthcare leaders emphasized a powerful reality: innovation alone is no longer enough. Organizations must focus on effective implementation, measurable outcomes, and collaborative execution.
From enterprise AI adoption to interoperability initiatives, from value-based care models to preventive health strategies, HLTH Europe 2026 showcased collective commitment to building a more connected, efficient, and sustainable healthcare ecosystem.
The Real Test Ahead
Healthcare’s next chapter will not be defined by breakthrough technologies alone. It will be defined by organizations and healthcare innovators capable of identifying unmet needs, translating innovation into action, and delivering meaningful impact for patients, providers, and society.
The question for the next generation of healthcare builders is simple: Which layer are you building in?
Because the answer to that question might matter more than how good your solution actually is.
The future belongs to those who understand that in healthcare, the connective tissue matters more than any individual thread.
A sincere thank you to the HLTH Europe team, especially Robbie Dorius and the HLTH organizers, for creating a platform that brings together some of the brightest minds in healthcare. The conversations that happened at this conference—between practitioners, innovators, and operators—are reshaping how an entire industry thinks about its future.
